Unknown

Dataset Information

0

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies.


ABSTRACT: BACKGROUND:Candida tropicalis is a virulent fungal pathogen for which echinocandins are the primary therapy. Emergence of resistance to echinocandins of C. tropicalis carries potentially ominous therapeutic implications. METHODS:We describe herein two patients with breakthrough C. tropicalis fungemia during echinocandin therapy, characterize their molecular mechanism of resistance, and systematically review 13 previously reported cases of echinocandin-resistant C. tropicalis bloodstream infections (BSIs) and other diseases. RESULTS:Among these 15 patients with echinocandin-resistant C. tropicalis infections, the median age was 61 years (ages 28-84 years) and 13 (86%) were immunocompromised. Thirteen (86%) of all patients had a history of pervious or concurrent exposure to echinocandins. Isolates of C. tropicalis from 11 cases, including the two index cases, underwent DNA sequencing of the FKS1 gene for mutations known to confer echinocandin resistance. The amino acid substitution Ser654Pro was shown in four cases, while other FKS1 mutations encoded Ser80S/Pro, Phe641Leu, Phe641Ser, Ser80S/Pro substitutions. These mutational events were not associated with collateral increases in minimum inhibitory concentrations to antifungal triazoles and amphotericin B. Overall mortality in patients with echinocandin-resistant C. tropicalis infections was 40%. Among those six patients who died, two received monotherapy with voriconazole, one was treated with fluconazole, one remained on caspofungin, and two were switched to liposomal amphotericin B. Nine patients (60%) survived after being treated with an antifungal agent other than an echinocandin. CONCLUSIONS:Emergence of resistance to echinocandins by C. tropicalis, occurs during antifungal therapy, is associated with high mortality, is mediated by a diverse range of FKS1 mutations, retains in vitro susceptibility to triazoles and amphotericin B, and constitutes an emerging threat to patients with hematological malignancies.

SUBMITTER: Sfeir MM 

PROVIDER: S-EPMC7151208 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant <i>Candida tropicalis</i>: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies.

Sfeir Maroun M MM   Jiménez-Ortigosa Cristina C   Gamaletsou Maria N MN   Schuetz Audrey N AN   Soave Rosemary R   Van Besien Koen K   Small Catherine B CB   Perlin David S DS   Walsh Thomas J TJ  

Journal of fungi (Basel, Switzerland) 20200131 1


<h4>Background</h4><i>Candida tropicalis</i> is a virulent fungal pathogen for which echinocandins are the primary therapy. Emergence of resistance to echinocandins of <i>C. tropicalis</i> carries potentially ominous therapeutic implications.<h4>Methods</h4>We describe herein two patients with breakthrough <i>C. tropicalis</i> fungemia during echinocandin therapy, characterize their molecular mechanism of resistance, and systematically review 13 previously reported cases of echinocandin-resistan  ...[more]

Similar Datasets

| S-EPMC2573122 | biostudies-literature
| S-EPMC5155041 | biostudies-literature
| S-EPMC7518979 | biostudies-literature
| S-EPMC5971591 | biostudies-literature
| S-EPMC8396981 | biostudies-literature
| S-EPMC3535961 | biostudies-literature
| S-EPMC6711239 | biostudies-literature
| S-EPMC4769087 | biostudies-other
| S-EPMC5913946 | biostudies-literature
| S-EPMC4003416 | biostudies-other